Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

NXTC

+ Watchlist+ Portfolio

NextCure, Inc.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$6.89
52-Week Range
$1.55 – $15.74
Market Cap
$31.05M
P/E (TTM)
—
EPS (TTM)
-6.78
Dividend Yield
0.00%
Advanced Metrics
Price/Book
5.64
PEG Ratio
—
Return on Equity
-281.11%
Return on Assets
-98.46%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
2.31
Debt/Equity
0.38
Total Debt
$0.00
Free Cash Flow
$-25.34M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$22.80M

Market Snapshot

About

NextCure is an immuno-oncology biotechnology company developing novel immunomedicines to treat cancer and other immune-related diseases. The company focuses on modulating the immune system to improve patient outcomes.